3 buy-rated blue chip ASX 200 shares according to experts


If you’re looking to bolster your portfolio with some blue chip shares, you may want to look at the three listed below.

Here’s why these blue chip ASX 200 shares are highly rated right now:

The first blue chip ASX 200 share to look at is CSL. It is a leading biotechnology company behind the CSL Behring and Seqirus businesses. Combined, these two businesses have a portfolio of life-saving and lucrative therapies and vaccines which are generating billions of dollars in sales each year. In addition, the company invests in the region of 10% to 11% of these sales back into research and development activities every year. This ensures that CSL has a pipeline of potentially lucrative products to drive its future growth. The proposed blockbuster acquisition of Vifor Pharma will also add to its portfolio and boost its growth outlook.

Citi is a fan and has a buy rating and $335.00 price target on CSL’s shares. Its analysts believe that plasma collections will rebound beyond pre-pandemic levels this year. Citi expects this to be a big boost to investor sentiment which could support a re-rating of its shares.

Another blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a portfolio of in-demand properties with exposure to key growth markets such as ecommerce. Thanks to strong demand and a material development pipeline, Goodman has been tipped to continue its solid growth in the coming years.

The team at Citi is also very positive on Goodman. Its analysts currently have a buy rating and $29.50 price target on the company’s shares. They believe the company could outperform its earnings guidance in FY 2022.

A final ASX blue chip ASX 200 share to look at is REA Group. It is a leading provider of property and property-related services via websites and mobile apps across Australia and Asia. It is best-known for the website which is dominating the ANZ market with 3.3 times more site visits than its nearest competitor. Looking ahead, thanks to this dominance, a strong housing market, and new acquisitions and revenue streams, REA Group appears well-positioned for long term growth.

Goldman Sachs is very positive on the company’s outlook. The broker currently has a buy rating rating and $167.00 price target on its shares.

Source: Read More

We’ve Already Come Too Far To End This Now.

Subscribe To Our Weekly Newsletter

Get notified about new articles